Section Arrow
ITOC.NASDAQ
- iTonic Holdings Ltd.
(Financial Status)
Quotes are at least 15-min delayed:2026/08/05 22:39 EDT
Regular Hours
Last
 0.29
0 (0.00%)
Day High 
0.2934 
Prev. Close
0.29 
1-M High
0.3399 
Volume 
63.09K 
Bid
0.281
Ask
0.29
Day Low
0.28 
Open
0.2864 
1-M Low
0.2192 
Market Cap 
4.94M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.27 
20-SMA 0.29 
50-SMA 0.31 
52-W High 1.18 
52-W Low 0.2192 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.32/--
Enterprise Value
4.94M
Balance Sheet
Book Value Per Share
0.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
523.03K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effectivebrachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.